indirubin has been researched along with Diabetes Mellitus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoda, N; Maqbool, M; Mobashir, M | 1 |
Alam, MS; Hamid, H; Khan, I; Tantray, MA | 1 |
Eisenbrand, G; Hippe, F; Jakobs, S; Muehlbeyer, S | 1 |
3 review(s) available for indirubin and Diabetes Mellitus
Article | Year |
---|---|
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Diabetes Mellitus; Glycogen Synthase Kinase 3; Hippocampus; Humans; Hypoglycemic Agents; Inflammation; Molecular Targeted Therapy; Neoplasms; Protein Kinase Inhibitors | 2016 |
Natural and synthetic bioactive inhibitors of glycogen synthase kinase.
Topics: Alzheimer Disease; Animals; Bipolar Disorder; Clinical Trials as Topic; Diabetes Mellitus; Drug Discovery; Glycogen Synthase Kinase 3; Humans; Models, Molecular; Neoplasms; Patents as Topic; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction | 2017 |
Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine.
Topics: Adenosine Triphosphate; Alzheimer Disease; Antibiotics, Antineoplastic; Cell Cycle; Cyclin-Dependent Kinases; Diabetes Mellitus; Enzyme Inhibitors; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Medicine, Chinese Traditional; Structure-Activity Relationship | 2004 |